Vision
- making life-changing medicines by utilizing our proprietary and patented Cell Penetration Protein Alternation (CePPA) TechnologyTM.
Mission
- developing transformative and versatile delivery platform that is applicable for drug and gene delivery in Ophthalmology, Dermatology, Otolaryngology and Neurology.
Collaborative Partnerships
- a science-driven operating model in collaboration with prestigious institutes
Established in 2019, and based at the Hong Kong Science Park, we conduct our core R&D at the Hong Kong Science Park facility and Company-sponsored Laboratory at the Fudan University (Shanghai). We also collaborate with the Byers Eye Institute at Stanford University; Johns Hopkins Wilmer Eye Institute; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, and The City University of Hong Kong. In addition, we outsource certain portion of the research and manufacturing processes to achieve the milestones globally.
